Expansion of human mesenchymal stem cells in fibrous bed bioreactor

Abstract Expansion of human mesenchymal stem cells (hMSCs) in bioreactor while preserving their innate properties is important in translation of hMSC-based therapy to clinical applications. The present study investigates the feasibility of hMSC expansion in a 2.5 L CelliGen ® 310 Bioreactor packed with Fibra-Cel ® disks. After 9 days of expansion, a 9.2-fold increase in cell number with the population doubling (PD) time of 2.8 days (67.2 h) was achieved and that the specific glucose consumption and lactate production were measured to be 12.48 pmol/cell/day and 20.95 pmol/cell/day, respectively. hMSCs harvested from the bioreactor maintained their properties based on the analysis of phenotypic surface markers, colony forming unit-fibroblasts (CFU-F) number, and multilineage differentiation ability. The results demonstrate the feasibility and the potential of the fibrous bed bioreactor for large scale hMSC expansion.

[1]  Osamu Honmou,et al.  Mesenchymal stem cells: therapeutic outlook for stroke. , 2012, Trends in molecular medicine.

[2]  Shangtian Yang,et al.  Expansion of human amniotic fluid stem cells in 3-dimensional fibrous scaffolds in a stirred bioreactor , 2014 .

[3]  Robert J. Thomas,et al.  Expansion of human mesenchymal stem cells on microcarriers , 2011, Biotechnology Letters.

[4]  Feng Zhao,et al.  Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. , 2005, Biotechnology and bioengineering.

[5]  W. Grayson,et al.  Perfusion affects the tissue developmental patterns of human mesenchymal stem cells in 3D scaffolds , 2009, Journal of cellular physiology.

[6]  J. Gimble,et al.  A xenogeneic‐free bioreactor system for the clinical‐scale expansion of human mesenchymal stem/stromal cells , 2014, Biotechnology and bioengineering.

[7]  T. Ma,et al.  Perfusion regulation of hMSC microenvironment and osteogenic differentiation in 3D scaffold , 2012, Biotechnology and bioengineering.

[8]  F Meuwly,et al.  Packed-bed bioreactors for mammalian cell culture: bioprocess and biomedical applications. , 2007, Biotechnology advances.

[9]  Joost D de Bruijn,et al.  Growth, metabolism, and growth inhibitors of mesenchymal stem cells. , 2009, Tissue engineering. Part A.

[10]  T. Ma,et al.  Endogenous extracellular matrices enhance human mesenchymal stem cell aggregate formation and survival , 2013, Biotechnology progress.

[11]  C. Hewitt,et al.  Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor , 2013, Biotechnology Letters.

[12]  M. Pittenger,et al.  Mesenchymal stem cells and their potential as cardiac therapeutics. , 2004, Circulation research.

[13]  Amir Toren,et al.  The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. , 2009, Cytotherapy.

[14]  T. Ma,et al.  Bioreactor strategy in bone tissue engineering: pre-culture and osteogenic differentiation under two flow configurations. , 2012, Tissue engineering. Part A.

[15]  W. T. Wu,et al.  A fiber‐bed bioreactor for anchorage‐dependent animal cell cultures: Part I. Bioreactor design and operations , 1991, Biotechnology and bioengineering.

[16]  W. Grayson,et al.  Human Mesenchymal Stem Cells Tissue Development in 3D PET Matrices , 2004, Biotechnology progress.

[17]  Shangtian Yang,et al.  Microfibrous carriers for integrated expansion and neural differentiation of embryonic stem cells in suspension bioreactor , 2013 .

[18]  D. Eibl,et al.  Scale‐up of adipose tissue‐derived mesenchymal stem cell production in stirred single‐use bioreactors under low‐serum conditions , 2014 .

[19]  R. Chella,et al.  Effects of shear stress on 3‐D human mesenchymal stem cell construct development in a perfusion bioreactor system: Experiments and hydrodynamic modeling , 2007, Biotechnology and bioengineering.

[20]  T. Ma,et al.  Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate. , 2015, Tissue engineering. Part A.

[21]  D. Hommes,et al.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study , 2010, Gut.

[22]  S. Reuveny,et al.  Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. , 2013, Biotechnology advances.

[23]  S. Teoh,et al.  The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. , 2012, Biomaterials.

[24]  Jon A. Rowley,et al.  Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy , 2012 .

[25]  M. A. Leroux,et al.  Treatment of inflammatory diseases with mesenchymal stem cells. , 2009, Inflammation & allergy drug targets.

[26]  A. Kadouri,et al.  Modified CelliGen-packed bed bioreactors for hybridoma cell cultures , 1992, Cytotechnology.

[27]  A. Fouras,et al.  Experimental Characterisation of Fluid Mechanics in a Spinner Flask Bioreactor , 2014 .